Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Kathleen Lumiere, DAOM, LAc
Dr. Kathleen Lumiere is co-president of the Seattle Institute of East Asian Medicine, and an adjunct faculty member at Bastyr University, NESA, and other schools. She is the founding editor of Convergent Points: An East-West Case Report Journal; and co-chairs Practice-Based Research, a Society for Acupuncture Research special-interest group.